Previous study had demonstrated that NF-κB activation promoted transcription of Bcl-2, VEGF, MMP and inhibited Bax expression, which reduced apoptosis and contributed to angiogenesis and progression of ESCC [26]. The gene discussed is NFKB1; the disease is esophageal squamous cell carcinoma.